|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2011-4-22
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
This study assessed the ability of the SYNTAX score (SXscore) to stratify risk in patients treated with percutaneous coronary intervention (PCI) using zotarolimus-eluting or everolimus-eluting stents.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1876-7605
|
|
pubmed:author |
pubmed-author:BartorelliAntonioA,
pubmed-author:BuszmanPawel EPE,
pubmed-author:DiMarioCarloC,
pubmed-author:GargScotS,
pubmed-author:GarotPhilippeP,
pubmed-author:HofmaSjoerd HSH,
pubmed-author:IschingerThomasT,
pubmed-author:KelbækHenningH,
pubmed-author:KlaussVolkerV,
pubmed-author:KornowskiRanR,
pubmed-author:LinkeAxelA,
pubmed-author:MacayaCarlosC,
pubmed-author:ManoharanGaneshG,
pubmed-author:RichardtGertG,
pubmed-author:RondenJacinthaJ,
pubmed-author:SerruysPatrick WPW,
pubmed-author:SilberSigmundS,
pubmed-author:Van RemortelEricE,
pubmed-author:WijnsWilliamW,
pubmed-author:WindeckerStephanS,
pubmed-author:WykrzykowskaJoannaJ,
pubmed-author:van BovenAdrianus JohannesAJ,
pubmed-author:van GeunsRobert JanRJ
|
|
pubmed:copyrightInfo |
Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
4
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
432-41
|
|
pubmed:meshHeading |
pubmed-meshheading:21511223-Aged,
pubmed-meshheading:21511223-Angioplasty, Balloon, Coronary,
pubmed-meshheading:21511223-Cardiovascular Agents,
pubmed-meshheading:21511223-Coronary Artery Disease,
pubmed-meshheading:21511223-Coronary Restenosis,
pubmed-meshheading:21511223-Drug-Eluting Stents,
pubmed-meshheading:21511223-Europe,
pubmed-meshheading:21511223-Female,
pubmed-meshheading:21511223-Health Status Indicators,
pubmed-meshheading:21511223-Humans,
pubmed-meshheading:21511223-Israel,
pubmed-meshheading:21511223-Kaplan-Meier Estimate,
pubmed-meshheading:21511223-Linear Models,
pubmed-meshheading:21511223-Male,
pubmed-meshheading:21511223-Middle Aged,
pubmed-meshheading:21511223-Myocardial Infarction,
pubmed-meshheading:21511223-Predictive Value of Tests,
pubmed-meshheading:21511223-Proportional Hazards Models,
pubmed-meshheading:21511223-Prospective Studies,
pubmed-meshheading:21511223-Prosthesis Design,
pubmed-meshheading:21511223-Risk Assessment,
pubmed-meshheading:21511223-Risk Factors,
pubmed-meshheading:21511223-Sirolimus,
pubmed-meshheading:21511223-Survival Rate,
pubmed-meshheading:21511223-Time Factors,
pubmed-meshheading:21511223-Treatment Outcome
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial.
|
|
pubmed:affiliation |
Department of Interventional Cardiology, Erasmus Medical Center, Rotterdam, the Netherlands.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
